Results
92
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
92 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
CALTX | SEK 206.20 | 0.2% | 130.9% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KEBNI B | SEK 1.45 | -4.0% | -5.2% | SEK 393.2m | SEK 2.20 | PS4.3x | E90.4% | n/a | Tech | ||
YUBICO | SEK 265.50 | 6.8% | 163.9% | SEK 22.9b | SEK 267.50 | PE138.1x | E43.8% | n/a | Software | ||
YIELD | SEK 2.44 | -7.2% | -65.5% | SEK 139.8m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
SILEON | SEK 0.50 | 2.0% | -88.5% | SEK 25.3m | n/a | PB1.6x | E109.3% | n/a | Software | ||
CTT | SEK 288.00 | -9.1% | 33.3% | SEK 3.6b | n/a | PE35.4x | E24.8% | 1.9% | Capital Goods | ||
MAGLE | SEK 45.20 | 5.1% | 31.4% | SEK 488.2m | SEK 50.00 | PE63.4x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
EDYOU | SEK 0.44 | -12.2% | -44.2% | SEK 16.4m | n/a | PB0.2x | E63.1% | n/a | Media | ||
BIOA B | SEK 225.60 | -4.4% | -24.1% | SEK 19.9b | SEK 368.00 | PS79x | E50.9% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.65 | 10.2% | -58.0% | SEK 222.7m | SEK 7.90 | PS30.5x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.27 | -7.0% | -28.8% | SEK 245.5m | SEK 3.65 | PS2.5x | E104.9% | n/a | Tech | ||
ORGC | SEK 3.55 | -9.9% | -22.8% | SEK 348.3m | SEK 3.00 | PS2.5x | E109.0% | n/a | Materials | ||
CRAD B | SEK 45.70 | 2.6% | 58.4% | SEK 1.5b | SEK 57.00 | PE28.8x | E33.9% | n/a | Healthcare | ||
FLEXQ | SEK 10.60 | -3.6% | -59.5% | SEK 142.1m | SEK 25.00 | PS1.1x | E111.9% | n/a | Capital Goods | ||
ORT B | SEK 9.48 | -15.4% | 33.9% | SEK 351.6m | SEK 19.50 | PS5.7x | E91.6% | n/a | Healthcare | ||
CTM | SEK 6.71 | 10.2% | -72.5% | SEK 507.6m | SEK 29.70 | PB0.3x | E115.4% | 0% | Media | ||
EQT | SEK 334.00 | -2.7% | 36.4% | SEK 395.2b | SEK 365.22 | PE112.4x | E56.6% | 1.1% | Diversified Financials | ||
TRUE B | SEK 33.26 | -5.4% | -25.8% | SEK 11.5b | SEK 54.83 | PE24.1x | E21.6% | 1.2% | Software | ||
4C | SEK 18.00 | -14.3% | -33.0% | SEK 632.4m | SEK 24.00 | PS2.2x | E89.6% | n/a | Software | ||
SENZA | SEK 7.25 | 2.8% | -33.8% | SEK 213.9m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
KLAR | SEK 0.34 | 15.0% | -39.5% | SEK 44.8m | SEK 1.00 | PB1.5x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
MIDS | SEK 1.23 | -6.1% | -51.0% | SEK 257.9m | SEK 2.80 | PS4x | E89.9% | n/a | Semiconductors | ||
FNOX | SEK 65.38 | 1.5% | 2.1% | SEK 39.9b | SEK 73.78 | PE61.4x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.95 | 17.1% | 34.5% | SEK 1.7b | SEK 13.30 | PS27.7x | E98.6% | n/a | Pharmaceuticals & Biotech |